| scholarly article | Q13442814 |
| editorial | Q871232 |
| P356 | DOI | 10.1165/RCMB.2012-0441ED |
| P698 | PubMed publication ID | 23378489 |
| P50 | author | Robin H Steinhorn | Q38328592 |
| P2093 | author name string | Steven H Abman | |
| John P Kinsella | |||
| P2860 | cites work | A randomized, double-blind, placebo-controlled, dose-ranging study of oral sildenafil citrate in treatment-naive children with pulmonary arterial hypertension | Q38480301 |
| Functional properties of a brain-specific NH2-terminally spliced modulator of Kv4 channels | Q42595294 | ||
| Population pharmacokinetics of sildenafil in term neonates: evidence of rapid maturation of metabolic clearance in the early postnatal period | Q42597721 | ||
| Intravenous sildenafil in the treatment of neonates with persistent pulmonary hypertension | Q43260002 | ||
| Long-term treatment with sildenafil citrate in pulmonary arterial hypertension: the SUPER-2 study | Q46694356 | ||
| Effect of preterm birth on hypoxia-inducible factors and vascular endothelial growth factor in primate lungs. | Q46758249 | ||
| Increased 36-week survival with high oxygen saturation target in extremely preterm infants. | Q51574827 | ||
| Oxygen-saturation targets and outcomes in extremely preterm infants. | Q52100740 | ||
| Intrauterine hypertension decreases lung VEGF expression and VEGF inhibition causes pulmonary hypertension in the ovine fetus. | Q52109383 | ||
| Hyperoxic injury decreases alveolar epithelial cell expression of vascular endothelial growth factor (VEGF) in neonatal rabbit lung. | Q52194865 | ||
| Disrupted pulmonary vasculature and decreased vascular endothelial growth factor, Flt-1, and TIE-2 in human infants dying with bronchopulmonary dysplasia. | Q52544695 | ||
| Hypoxia-inducible factors HIF-1alpha and HIF-2alpha are decreased in an experimental model of severe respiratory distress syndrome in preterm lambs. | Q52577117 | ||
| Oral Sildenafil in Infants With Persistent Pulmonary Hypertension of the Newborn: A Pilot Randomized Blinded Study | Q56636803 | ||
| Studies on the activity of the hypoxia-inducible-factor hydroxylases using an oxygen consumption assay | Q24671869 | ||
| Bronchopulmonary dysplasia | Q28201380 | ||
| Vascular endothelial growth factor gene therapy increases survival, promotes lung angiogenesis, and prevents alveolar damage in hyperoxia-induced lung injury: evidence that angiogenesis participates in alveolarization | Q28571824 | ||
| Glu496Ala polymorphism of human P2X7 receptor does not affect its electrophysiological phenotype | Q30320749 | ||
| Microtubule-dependent PKC-alpha localization in A7r5 smooth muscle cells | Q30897895 | ||
| Inhibition of oxygen sensors as a therapeutic strategy for ischaemic and inflammatory disease | Q33402434 | ||
| Sildenafil alleviates bronchopulmonary dysplasia in neonatal rats by activating the hypoxia-inducible factor signaling pathway | Q33756664 | ||
| SOD and inhaled nitric oxide normalize phosphodiesterase 5 expression and activity in neonatal lambs with persistent pulmonary hypertension | Q33994653 | ||
| Inhaled nitric oxide in preterm infants: an individual-patient data meta-analysis of randomized trials | Q34022590 | ||
| Mitochondrial oxidant stress increases PDE5 activity in persistent pulmonary hypertension of the newborn. | Q34348585 | ||
| Moderate postnatal hyperoxia accelerates lung growth and attenuates pulmonary hypertension in infant rats after exposure to intra-amniotic endotoxin | Q34426107 | ||
| Sildenafil improves alveolar growth and pulmonary hypertension in hyperoxia-induced lung injury | Q34558395 | ||
| Nonventilatory strategies for prevention and treatment of bronchopulmonary dysplasia--what is the evidence? | Q34804138 | ||
| Bronchopulmonary dysplasia: where have all the vessels gone? Roles of angiogenic growth factors in chronic lung disease | Q36330521 | ||
| Intrauterine pulmonary hypertension impairs angiogenesis in vitro: role of vascular endothelial growth factor nitric oxide signaling | Q36330558 | ||
| Hyperoxia increases phosphodiesterase 5 expression and activity in ovine fetal pulmonary artery smooth muscle cells | Q36498599 | ||
| Sildenafil attenuates pulmonary inflammation and fibrin deposition, mortality and right ventricular hypertrophy in neonatal hyperoxic lung injury. | Q37190561 | ||
| Oxygen in health and disease: regulation of oxygen homeostasis--clinical implications | Q37293099 | ||
| Effects of long-term sildenafil treatment for pulmonary hypertension in infants with chronic lung disease | Q37308066 | ||
| Impaired vascular endothelial growth factor signaling in the pathogenesis of neonatal pulmonary vascular disease | Q37702971 | ||
| Inhaled nitric oxide in preterm infants: a systematic review | Q37827270 | ||
| P433 | issue | 2 | |
| P921 | main subject | lung disease | Q3392853 |
| P304 | page(s) | iii-v | |
| P577 | publication date | 2013-02-01 | |
| P1433 | published in | American Journal of Respiratory Cell and Molecular Biology | Q4744268 |
| P1476 | title | Beyond pulmonary hypertension: sildenafil for chronic lung disease of prematurity | |
| P478 | volume | 48 |
Search more.